Forschung Archive - Seite 3 von 9 - Psychedelische Gesellschaft Deutschland

Psychedelic mushrooms reduce authoritarianism and boost nature relatedness, experimental study suggests

von pgd | Jan. 25, 2018 | Forschung

Psilocybin, the active compound in magic mushrooms, could make people feel more connected to nature and less likely to endorse authoritarian views, according to new research from the Psychedelic Research Group at Imperial College London.The new study, published in the...

Frontiers | Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression | Pharmacology

von pgd | Jan. 17, 2018 | Forschung

It is a basic principle of the “psychedelic” treatment model that the quality of the acute experience mediates long-term improvements in mental health. In line with previous reports, we hypothesized that the occurrence and magnitude of Oceanic Boundlessness (OBN)...

Magic Mushrooms Do The Opposite of Anti-Depressants, But That May Be Why They Work

von pgd | Jan. 16, 2018 | Forschung

Psychedelic therapy is going through something of a revival right now, and we may now know how one such hallucinogenic drug is seemingly able to alleviate symptoms of depression. Psilocybin, the active compound in magic mushrooms, has long been known to deliver...

Depressed patients who are treated with antidepressants do worse in the long run – MedicalXPress

von pgd | Okt. 26, 2017 | Forschung

In der aktuellen Ausgabe von „Psychotherapy and Psychosomatics“ offenbart eine neue Analyse Einsichten in Langzeiteffekte von Antidepressiva. Neun Jahre nach der Behandlung waren die depressiven Symptome deutlich erhöht gegenüber der Behandlung ohne...

All clear for the decisive trial of ecstasy in PTSD patients | Science | AAAS

von pgd | Aug. 30, 2017 | Forschung

Nonprofit seeks funding for phase III trials after Food and Drug Administration grants MDMA „breakthrough therapy“ status One of the main targets in the war on drugs could well become a drug to treat the scars of war. The U.S. Food and Drug Administration...

‚Ego-dissolving‘ psychedelic drugs could assist with mental health – MedicalXpress

von pgd | Aug. 22, 2017 | Forschung

The altered state of consciousness and temporary lack of ego that results from using psychedelic drugs could help some mental health patients recover from their symptoms, according to academics at the University of Adelaide. Researchers in the University’s...

« Ältere Einträge

Nächste Einträge »